Drug
Senicapoc clinical trials
Also written ICA-17043.
- studies test it
- 10
- open now
- 4
- in phase 3
- 2
- first study started
- 2002
Keep track of what changes. Save the senicapoc studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2026 (2)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 2
- 7
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 4
Icagen (5) · University of California, Davis (1) · Biossil Inc. (1) · Vejle Hospital (1) · Aarhus University Hospital (1) · University of Aarhus (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses senicapoc is read from its arms, and is right about nine times in ten.
Testing it · 10
- Senicapoc in Alzheimer's DiseaseRecruitingPhase 2University of California, DavisNCT04804241Written as Senicapoc
- Efficacy and Safety of SIL-8301 for Control of Hemolysis in a Uniform Sickle Cell Disease EndotypeRecruitingPhase 2Biossil Inc.NCT07282210Written as Senicapoc
- Senicapoc in Patients With Worsening Fibrotic Interstitial Lung DiseaseRecruitingPhase 2Vejle HospitalNCT06714123Written as Senicapoc
- Senicapoc and Perampanel for Newly Diagnosed GlioblastomaRecruitingEarly Phase 1Aarhus University HospitalNCT07284069Written as senicapoc
- Senicapoc in COVID-19 Patients With Severe Respiratory InsufficiencyStatus unknownPhase 2University of AarhusNCT04594668Written as Senicapoc
- A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.CompletedPhase 2IcagenNCT00040677Written as Low Dose ICA-17043
- Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced AsthmaCompletedPhase 2IcagenNCT00861185Written as senicapoc
- Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic SubjectsCompletedPhase 2IcagenNCT00861211Written as senicapoc
- A Stratified Sickle Event Randomized Trial (ASSERT)TerminatedPhase 3IcagenNCT00102791Written as ICA-17043
- A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea TherapyTerminatedPhase 3IcagenNCT00294541Written as ICA-17043
Codes
What other systems call senicapoc · ClinicalTrials.gg INT004518
- MeSH (NLM) C472774senicapocConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) TS6G201A6QSENICAPOCConfirmed FDA, NLM, Wikidata
- Wikidata Q7450628senicapocConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76882SenicapocOne source FDA
- DrugBank DB06280One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C472774 | senicapoc | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | TS6G201A6Q | SENICAPOC | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7450628 | senicapoc | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76882 | Senicapoc | One source FDA |
| DrugBank | DB06280 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.